Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,454,261
+$423,104 QoQ
Shares Held
13,727
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#1,552
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 11%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADIRONDACK TRUST CO holds $16,941,363 across 11 Drug Manufacturers - General names. ABBV ranks #3 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
19,692 | $5,001,176 | |
| 2 | LLY |
ELI LILLY & Co
|
3,642 | $4,368,324 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
13,727 | $3,454,261 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
19,711 | $1,135,747 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,753 | $1,124,760 | |
| 6 | AMGN |
Amgen Inc
|
2,529 | $915,801 | |
| 7 | PFE |
Pfizer Inc
|
23,149 | $557,427 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,872 | $236,508 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,454,261 | 13,727 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,031,157 | 13,937 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $3,250,726 | 14,227 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $3,374,000 | 14,572 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,958,040 | 15,936 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $3,339,119 | 15,937 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $2,874,652 | 16,177 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,207,075 | 16,240 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $2,733,856 | 15,939 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,911,414 | 15,988 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $2,496,101 | 16,107 | Shares | Sole | 2024-03-29 | |
| 2023-09-30 | $2,392,859 | 16,053 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,148,404 | 15,946 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,579,084 | 16,183 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2,609,839 | 16,149 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,166,282 | 16,141 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,458,217 | 16,050 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $2,529,240 | 15,602 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $1,945,427 | 14,368 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $1,543,403 | 14,308 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,601,965 | 14,222 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,519,083 | 14,037 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $1,410,307 | 13,162 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,171,691 | 13,377 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $1,323,171 | 13,477 | Shares | Sole | 2020-08-19 | |
| 2020-03-31 | $1,024,678 | 13,449 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||